PATENT CLAIM ANALYSIS

Application Number: 16089547
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "226000"]

Abstract:
The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, a solvate, an ester, an acid, a metabolite or a prodrug thereof. The compound itself in the present invention or in combination with at least one therapeutic agent can be used for preventing or treating diseases, disorders or symptoms caused by the adjustment of the activity of tyrosine kinase C-KIT, or affected by the activity of the tyrosine kinase C-KIT or involving in the activity of the tyrosine kinase C-KIT, especially cancers or other cell proliferation diseases.

Claim (Index 3):
The compound, or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite or prodrug thereof, as claimed in  claim 1 , wherein R 1  is selected from the group consisting of H, methyl, methoxy, and chloro.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.7931
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13807678', '16062399', '11921781', '12673254', '12520609']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7935283539980033
- 35 USC 102 Novelty (BERT): 0.5273483783128221
- Combined Prediction Score: 0.7669103564294851
- Mean Citation Score: 310.256208
- Max Citation Score: 342.39252
- Similarity Product: 260.1648628994107

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test